<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-28T20:22:24Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/123521" metadataPrefix="rdf">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/123521</identifier><datestamp>2025-08-29T23:48:20Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:docta.ucm.es:20.500.14352/123521">
      <dc:title>Unlocking the potential of NH2-MIL-101 (Fe) nanoMOF for advanced electrochemical immunosensing in chronic wound diagnostics</dc:title>
      <dc:creator>Pérez Ginés, Víctor</dc:creator>
      <dc:creator>Valero-Calvo, David</dc:creator>
      <dc:creator>Torrente Rodríguez, Rebeca Magnolia</dc:creator>
      <dc:creator>Pedrero Muñoz, María</dc:creator>
      <dc:creator>García Alonso, Francisco J.</dc:creator>
      <dc:creator>Pingarrón Carrazón, José Manuel</dc:creator>
      <dc:creator>Campuzano Ruiz, Susana</dc:creator>
      <dc:creator>Escosura Muniz, Alfredo de la</dc:creator>
      <dc:description>In this work we take advantage, for the first time, of the porous and functional structure of a nanoscale metal organic framework (nanoMOF), specifically NH2-MIL-101 (Fe) nanoMOF, for its use as advantageous enzyme-carrier nanotag in immunoassays. In particular, the porous structure of the nanoMOF allows accommodating a high loading of enzyme molecules, which, in addition, are protected from degradation inside the pores providing a high stability. This property together with the ability of the nanoMOF to link antibodies through its functional groups make it a very robust and powerful label. Both the enhanced sensitivity, compared with the conventional use of enzyme-labelled antibodies, and the high long-term stability are demonstrated. Such nanotag also offers advantages related to ease of modification and cost effectiveness. The detection of myeloperoxidase (MPO), a key biomarker for chronic wound monitoring, is proposed to demonstrate the applicability of this approach. A sandwich-type immunoassay using magnetic beads (MBs)-based platforms and subsequent amperometric detection allows the determination of MPO in the clinical range (5 – 100 ng mL−1), with a limit of detection of 1.4 ng mL−1, and good reproducibility (RSD(n = 10) = 7.1 %). The developed bio-strategy also exhibits high selectivity against potential interferents and a good stability of the nanotag for at least 2 months. Moreover, the developed method was successfully implemented to determine MPO in simulated chronic wound matrices, demonstrating its feasibility in a real scenario.</dc:description>
      <dc:date>2025-08-29T09:24:30Z</dc:date>
      <dc:date>2025-08-29T09:24:30Z</dc:date>
      <dc:date>2025</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Víctor Pérez-Ginés, David Valero-Calvo, Rebeca M. Torrente-Rodríguez, María Pedrero, Francisco J. García-Alonso, José M. Pingarrón, Susana Campuzano, Alfredo de la Escosura-Muñiz, Unlocking the potential of NH2-MIL-101 (Fe) nanoMOF for advanced electrochemical immunosensing in chronic wound diagnostics, Sensors and Actuators B: Chemical, Volume 432, 2025, 137460, ISSN 0925-4005, https://doi.org/10.1016/j.snb.2025.137460.</dc:identifier>
      <dc:identifier>10.1016/j.snb.2025.137460</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.14352/123521</dc:identifier>
      <dc:identifier>https://doi.org/10.1016/j.snb.2025.137460</dc:identifier>
      <dc:identifier>https://www.sciencedirect.com/science/article/pii/S0925400525002357?via%3Dihub</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>PID2020-115204RB-I00</dc:relation>
      <dc:relation>RED2022-134120-T</dc:relation>
      <dc:relation>info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-136351OB-I00/ES/BIOSENSORES ELECTROQUIMICOS EMPODERADOS PARA TRAZAR NUEVAS HOJAS DE RUTA HACIA LA MEDICINA PERSONALIZADA DEL CANCER, EL ALZHEIMER Y LAS ENFERMEDADES INFECCIOSAS VIRALES/</dc:relation>
      <dc:rights>open access</dc:rights>
      <dc:publisher>Elsevier</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>